Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 373,885 | 153,119 | 246,810 | 264,291 | 6,489 |
| General And Administrative Expense | 359,853 | 143,555 | 242,681 | 259,291 | 6,489 |
| Research And Development | 92.00 | 0.00 | -- | -- | 0.00 |
| Other Operating Expenses | -- | -- | -- | 480.00 | -- |
| Operating Expense | 373,977 | 153,119 | 247,311 | 264,771 | 6,489 |
| Operating Income | -373,977 | -153,119 | -247,311 | -264,771 | -6,489 |
| EBIT | -373,977 | -153,119 | -247,311 | -264,771 | -6,489 |
| Interest Income | -- | 55,315 | 10,271 | 5,119 | 0.00 |
| Interest Income Non Operating | -- | 55,315 | 10,271 | 5,119 | 0.00 |
| Net Interest Income | -- | 55,315 | 10,271 | 5,119 | 0.00 |
| Other Income Expense | 241,613 | -- | -33,513 | -409,030 | -- |
| Other Non Operating Income Expenses | 279,106 | -- | -- | -- | -- |
| Special Income Charges | -39,493 | 0.00 | -33,513 | -409,030 | 0.00 |
| Write Off | 28,056 | 0.00 | 33,033 | 409,030 | 0.00 |
| Pretax Income | -203,069 | -97,804 | -270,553 | -668,682 | -6,489 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -203,070 | -97,804 | -270,554 | -668,681 | -6,489 |
| Net Income From Continuing Operation Net Minority Interest | -203,070 | -97,804 | -270,554 | -668,681 | -6,489 |
| Net Income Including Noncontrolling Interests | -203,069 | -97,804 | -270,553 | -668,682 | -6,489 |
| Net Income Common Stockholders | -203,070 | -97,804 | -270,554 | -668,681 | -6,489 |
| Net Income | -203,070 | -97,804 | -270,554 | -668,681 | -6,489 |
| EBITDA | -373,977 | -153,119 | -247,311 | -264,771 | -6,489 |
| Normalized EBITDA | -336,484 | -153,119 | -213,798 | 144,259 | -6,489 |
| Basic EPS | -- | 0.00 | -- | -0.01 | -0.00 |
| Diluted EPS | -- | 0.00 | -- | -0.01 | -0.00 |
| Basic Average Shares | -- | 64.6M | -- | 63.3M | 63.3M |
| Diluted Average Shares | -- | 64.6M | -- | 63.3M | 63.3M |
| Total Unusual Items | -37,493 | 0.00 | -33,513 | -409,030 | 0.00 |
| Total Unusual Items Excluding Goodwill | -37,493 | 0.00 | -33,513 | -409,030 | 0.00 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -165,577 | -97,804 | -237,041 | -259,651 | -6,489 |
| Diluted NI Availto Com Stockholders | -203,070 | -97,804 | -270,554 | -668,681 | -6,489 |
| Impairment Of Capital Assets | 11,437 | 0.00 | -- | -- | 0.00 |
| Net Income Continuous Operations | -203,069 | -97,804 | -270,553 | -668,682 | -6,489 |
| Net Non Operating Interest Income Expense | -- | 55,315 | 10,271 | 5,119 | 0.00 |
| Other Gand A | 307,425 | 97,700 | 178,274 | 63,031 | 6,489 |
| Other Taxes | -- | 0.00 | -- | -- | 0.00 |
| Salaries And Wages | 52,428 | 45,855 | 64,407 | 196,260 | 0.00 |
| Selling And Marketing Expense | 14,032 | 9,564 | 4,129 | 5,000 | 0.00 |
| Total Expenses | 373,977 | 153,119 | 247,311 | 264,771 | 6,489 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 1.1M | 2.0M | 1.1M | 1.4M | 99,699 |
| Cash Cash Equivalents And Short Term Investments | 1.3M | 2.0M | 1.1M | 1.4M | 99,699 |
| Cash Equivalents | 29,267 | -- | -- | -- | -- |
| Cash Financial | 1.1M | 2.0M | 1.1M | 1.4M | 99,699 |
| Other Short Term Investments | 138,000 | -- | -- | -- | -- |
| Receivables | 109,655 | 101,399 | 11,400 | 4,742 | 234.00 |
| Prepaid Assets | 935,551 | 1.2M | 980,788 | 926,933 | -- |
| Current Assets | 2.3M | 3.2M | 2.1M | 2.3M | 99,933 |
| Net PPE | 8.2M | 7.2M | 7.0M | 7.0M | -- |
| Total Non Current Assets | 8.2M | 7.2M | 7.0M | 7.0M | 0.00 |
| Total Assets | 10.5M | 10.4M | 9.1M | 9.3M | 99,933 |
| Accounts Payable | 350,943 | -- | -- | -- | -- |
| Payables | 350,943 | -- | -- | -- | -- |
| Payables And Accrued Expenses | 523,612 | 58,534 | 44,922 | 16,527 | 121,421 |
| Current Accrued Expenses | 172,669 | -- | -- | -- | -- |
| Other Current Liabilities | 20,562 | 268,902 | -- | -- | -- |
| Current Liabilities | 544,174 | 327,436 | 44,922 | 16,527 | 121,421 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 544,174 | 327,436 | 44,922 | 16,527 | 121,421 |
| Common Stock | 10.3M | 10.3M | 9.2M | 9.2M | 1.00 |
| Capital Stock | 10.3M | 10.3M | 9.2M | 9.2M | 1.00 |
| Retained Earnings | -1.9M | -1.7M | -1.6M | -1.4M | -21,489 |
| Gains Losses Not Affecting Retained Earnings | 1.6M | 1.6M | 1.5M | 1.5M | -- |
| Common Stock Equity | 10.0M | 10.1M | 9.1M | 9.3M | -21,488 |
| Stockholders Equity | 10.0M | 10.1M | 9.1M | 9.3M | -21,488 |
| Total Equity Gross Minority Interest | 10.0M | 10.1M | 9.1M | 9.3M | -21,488 |
| Total Capitalization | 10.0M | 10.1M | 9.1M | 9.3M | -21,488 |
| Net Tangible Assets | 10.0M | 10.1M | 9.1M | 9.3M | -21,488 |
| Tangible Book Value | 10.0M | 10.1M | 9.1M | 9.3M | -21,488 |
| Working Capital | 1.8M | 2.9M | 2.1M | 2.3M | -21,488 |
| Invested Capital | 10.0M | 10.1M | 9.1M | 9.3M | -21,488 |
| Share Issued | 78.0M | 77.3M | 63.3M | 63.3M | 63.3M |
| Ordinary Shares Number | 78.0M | 77.3M | 63.3M | 63.3M | 63.3M |
| Other Receivables | -- | -- | -- | -- | 234.00 |
| Taxes Receivable | 109,655 | 101,399 | 11,400 | 4,742 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | 274,601 | -331,329 | -249,693 | -647,964 | -- |
| Cash Flow From Continuing Operating Activities | 265,404 | -322,132 | -249,693 | -647,964 | -- |
| Stock Based Compensation | 21,435 | 47,153 | 52,979 | 195,456 | -- |
| Change In Working Capital | 611,837 | -718,072 | -32,118 | -174,739 | -- |
| Change In Receivables | 2,843 | -101,098 | -6,658 | -4,317 | -- |
| Change In Payables And Accrued Expense | 403,290 | 13,612 | 28,395 | 11,293 | -- |
| Other Non Cash Items | 65,864 | -- | -- | -- | -- |
| Capital Expenditure | -1.1M | -154,191 | -23,654 | -79,149 | -- |
| Purchase Of PPE | -1.1M | -154,191 | -23,654 | -79,149 | -- |
| Net PPE Purchase And Sale | -1.1M | -154,191 | -23,654 | -79,149 | -- |
| Purchase Of Investment | -- | -- | -- | -28,750 | -- |
| Net Investment Purchase And Sale | -- | -- | -- | -28,750 | -- |
| Investing Cash Flow | -1.1M | -154,191 | 5,096 | -107,899 | -- |
| Cash Flow From Continuing Investing Activities | -1.1M | -154,191 | 5,096 | -107,899 | -- |
| Issuance Of Capital Stock | 0.00 | 1.4M | 0.00 | 2.1M | -- |
| Net Common Stock Issuance | 0.00 | 1.4M | 0.00 | 2.1M | -- |
| Financing Cash Flow | -1,647 | 1.3M | 0.00 | 2.1M | -- |
| Cash Flow From Continuing Financing Activities | -1,647 | 1.3M | 0.00 | 2.1M | -- |
| Changes In Cash | -825,727 | 822,952 | -244,596 | 1.3M | -- |
| Beginning Cash Position | 2.0M | 1.1M | 1.4M | 70,089 | -- |
| End Cash Position | 1.1M | 2.0M | 1.1M | 1.4M | -- |
| Free Cash Flow | -874,080 | -485,520 | -273,347 | -727,113 | -- |
| Asset Impairment Charge | 39,973 | -- | -- | -- | -- |
| Change In Prepaid Assets | 205,704 | -630,586 | -53,855 | -181,715 | -- |
| Common Stock Issuance | 0.00 | 1.4M | 0.00 | 2.1M | -- |
| Net Income From Continuing Operations | -203,070 | -93,276 | -270,554 | -668,681 | -- |
| Net Other Financing Charges | -1,647 | -91,528 | 0.00 | -22,620 | -- |